Methylenetetrahydrofolate reductase polymorphism in childhood primary focal segmental glomerulosclerosis

Nephron

Volumn 92, Issue 2, 2002, Pages 449-451

  Zou, Chaochun ^a   Tsukahara, Hirokazu ^a   Hiraoka, Masahiro ^a   Mizu, Jiang ^a   Todoroki, Yukiko ^a   Ohshima, Yusei ^a   Kimura, Hideki ^a   Tsuzuki, Kazuo ^b   Mayumi, Mitsufumi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b CHUKYO HOSPITAL   (Japan)

Author keywords

Children; Focal segmental glomerulosclerosis; Methylenetetrahydrofolate reductase; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; GLOMERULOSCLEROSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENOTYPE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0036420518     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063283     Document Type: Article

References (8)

1. Barratt TM, Clark G: Minimal change nephrotic syndrome and focal segmental glomerulosclerosis; in Holliday MA, Barratt TM, Avner ED, Kogan BA (eds): Pediatric Nephrology. Baltimore, Williams & Wilkins, 1994, pp 767-787.
2. Hori C, Hiraoka M, Yoshikawa N, Tsuzuki K, Yoshida Y, Yoshioka K, Fujisawa K, Tsukahara H, Ohshima Y, Mayumi M: Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis. Nephron 2001;88:313-319.
3. Miner SE, Evrovski J, Cole DE: Clinical chemistry and molecular biology of homocysteine metabolism: An update. Clin Biochem 1997;30:189-201.
4. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T, Ohno M, Yamaoki K, Ogasawara K, Aizawa T, Suzuki S, Yazaki Y: Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997;95:2032-2036.
5. Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Kitamura K, Yazaki Y: Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol 1998;18:1465-1469.
6. Neugebauer S, Baba T, Watanabe T: Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet 1998;352:454.
7. Noiri E, Taguchi J, Nakao A, Fujita T: MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes: Analysis in Japanese male hemodialysis patients. Diab Care 2000;23:260.
8. Kimura H, Gejyo F, Suzuki S, Miyazaki R: The C677T methylenetetrahydrofolate reductase gene mutation in hemodialysis patients. J Am Soc Nephrol 2000;11:885-893.